How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

74,949 results for

Serum Glucose

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

241. Correlation between Salivary Glucose and Blood Glucose and the Implications of Salivary Factors on the Oral Health Status in Type 2 Diabetes Mellitus Patients Full Text available with Trip Pro

Correlation between Salivary Glucose and Blood Glucose and the Implications of Salivary Factors on the Oral Health Status in Type 2 Diabetes Mellitus Patients The purpose of this study was to estimate and assess any correlation between random capillary blood glucose (RCBG) and unstimulated whole salivary glucose (UWSG), as well as to estimate various salivary parameters, such as flow rate, pH, buffering capacity, and the influence of these factors on the oral health status in type 2 diabetes (...) version 16 was used for statistical analysis.Type 2 diabetics had higher mean values for RCBG levels and UWSG. Type 2 diabetics had low mean salivary flow rate, pH, and buffering capacity. Type 2 diabetics had higher mean values for RPI.Among the salivary factors studied, salivary glucose significantly influenced the periodontal status in Type 2 diabetics.

2017 Journal of International Society of Preventive & Community Dentistry

242. Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes Full Text available with Trip Pro

Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes Published evaluations of sensor glucose monitoring use in insulin treated type 2 diabetes are limited. The aim of this study was to assess the impact of flash glucose-sensing technology as a replacement for self-monitoring of blood glucose (SMBG) over a 12-month period in participants with type 2 diabetes who were on intensive insulin therapy.An open-label (...) , randomized, controlled study in adults with type 2 diabetes on intensive insulin therapy from 26 European diabetes centers aimed at assessing flash glucose sensing technology was conducted. Participants (N = 224) were randomized (1:2 respectively) to a control group (n = 75) that used SMBG (FreeStyle Lite™) or to an intervention group (n = 149) which used sensor glucose data (FreeStyle Libre™ Flash Glucose Monitoring System) for self-management over 6 months. All intervention group participants who

2017 Diabetes Therapy Controlled trial quality: uncertain

243. Twenty‐four‐hour variations in blood glucose level in Japanese type 2 diabetes patients based on continuous glucose monitoring Full Text available with Trip Pro

Twenty‐four‐hour variations in blood glucose level in Japanese type 2 diabetes patients based on continuous glucose monitoring High fluctuations in blood glucose are associated with various complications. The correlation between glycated hemoglobin (HbA1c) level and fluctuations in blood glucose level has not been studied in Japanese patients with type 2 diabetes. In the present study, blood glucose profile stratified by HbA1c level was evaluated by continuous glucose monitoring (CGM (...) ) in Japanese type 2 diabetes patients.Our retrospective study included 294 patients with type 2 diabetes who were divided by HbA1c level into five groups (≥6.0 to <7.0%, ≥7.0 to <8.0%, ≥8.0 to <9.0%, ≥9.0 to <10.0% and ≥10%). The correlation between HbA1c level and CGM data was analyzed. The primary end-point was the difference in blood glucose fluctuations among the HbA1c groups.The mean blood glucose level increased significantly with increasing HbA1c (Ptrend  < 0.01). The standard deviation increased

2017 Journal of Diabetes Investigation

244. Corticosterone and exogenous glucose alter blood glucose levels, neurotoxicity, and vascular toxicity produced by methamphetamine Full Text available with Trip Pro

Corticosterone and exogenous glucose alter blood glucose levels, neurotoxicity, and vascular toxicity produced by methamphetamine Our previous studies have raised the possibility that altered blood glucose levels may influence and/or be predictive of methamphetamine (METH) neurotoxicity. This study evaluated the effects of exogenous glucose and corticosterone (CORT) pretreatment alone or in combination with METH on blood glucose levels and the neural and vascular toxicity produced. METH (...) alone did not significantly increase blood glucose. Mortality rates for the METH+CORT (40%) and METH+Glucose (44%) groups were substantially higher than the METH (< 10%) group. Additionally, METH+CORT significantly increased neurodegeneration above the other three METH treatment groups (≈ 2.5-fold in the parietal cortex). Thus, maintaining elevated levels of glucose during METH exposure increases lethality and may exacerbate neurodegeneration. Neuroinflammation, specifically microglial activation

2017 Journal of neurochemistry

245. Interstitial Glucose and Lactate Levels Are Inversely Correlated With the Body Mass Index: Need for In Vivo Calibration of Glucose Sensor Results With Blood Values in Obese Patients Full Text available with Trip Pro

Interstitial Glucose and Lactate Levels Are Inversely Correlated With the Body Mass Index: Need for In Vivo Calibration of Glucose Sensor Results With Blood Values in Obese Patients Continuously measured glucose and lactate levels in interstitial fluid (ISF) may markedly differ from their respective blood levels.Combining microdialysis with a bioanalytical microsystem, the interstitial glucose and lactate concentrations of eight male volunteers with different body mass index (BMI) were (...) for glucose, R2 = .609 for lactate, P < .05). One subject with a BMI of > 34 kg/m2 showed abdominally as well as the antebrachially significantly reduced tissue glucose values compared to blood glucose values ( P < .001).A very good correlation between abdominally measured sensor results and the results of the reference method verified the reliability of the BioMEMS. The abdominally measured glucose level in ISF decreased significantly with increasing BMI. Therefore, an in vivo calibration of glucose

2017 Journal of diabetes science and technology

246. The association between Western and Prudent dietary patterns and fasting blood glucose levels in type 2 diabetes and normal glucose metabolism in older Australian adults Full Text available with Trip Pro

The association between Western and Prudent dietary patterns and fasting blood glucose levels in type 2 diabetes and normal glucose metabolism in older Australian adults High blood glucose and type 2 diabetes are associated with a range of adverse health and cognitive outcomes. One factor that contributes to high blood glucose and type 2 diabetes is dietary intake. This study investigated the relationship between dietary patterns, fasting blood glucose and diabetes status in a sample of 209 (...) participants aged 60-65. Blood plasma glucose was measured from venous blood samples. Individual Prudent and Western dietary patterns were estimated from a self-completed food frequency questionnaire. The relationship between dietary patterns, diabetes, and blood glucose was assessed via general linear model analyses controlling for age, sex, height, and total caloric intake. Results indicated that there was no association between Prudent diet and fasting blood glucose levels, or type 2 diabetes

2017 Heliyon

247. Sodium–glucose cotransporter 2 inhibitor, tofogliflozin, shows better improvements of blood glucose and insulin secretion in patients with high insulin levels at baseline Full Text available with Trip Pro

Sodium–glucose cotransporter 2 inhibitor, tofogliflozin, shows better improvements of blood glucose and insulin secretion in patients with high insulin levels at baseline Sodium glucose cotransporter 2 (SGLT2) inhibitors are a new class of drugs for the treatment of type 2 diabetes mellitus that improve control of plasma glucose and bodyweight, giving great hope for the clinical utility of these agents. However, it is unclear for which patients SGLT2 inhibitors will be useful.We analyzed data (...) from long-term tofogliflozin monotherapy in an open-label, randomized controlled trial in Japanese patients with type 2 diabetes mellitus. Patients were divided into tertiles by baseline insulin level: group low (L): insulin ≤5.6 μU/mL, group medium (M): 5.6< insulin ≤10 μU/mL and group high (H): insulin >10 μU/mL.Glycated hemoglobin and fasting plasma glucose levels, along with bodyweight, were significantly reduced from the baseline in all groups. The changes in levels of plasma glucose area

2017 Journal of Diabetes Investigation Controlled trial quality: uncertain

248. Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production Full Text available with Trip Pro

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production Glucagon is secreted from pancreatic α cells, and hypersecretion (hyperglucagonemia) contributes to diabetic hyperglycemia. Molecular heterogeneity in hyperglucagonemia is poorly investigated. By screening human plasma using high-resolution-proteomics, we identified several glucagon variants, among which proglucagon 1-61 (PG 1-61) appears to be the most abundant form. PG 1-61 (...) is secreted in subjects with obesity, both before and after gastric bypass surgery, with protein and fat as the main drivers for secretion before surgery, but glucose after. Studies in hepatocytes and in β cells demonstrated that PG 1-61 dose-dependently increases levels of cAMP, through the glucagon receptor, and increases insulin secretion and protein levels of enzymes regulating glycogenolysis and gluconeogenesis. In rats, PG 1-61 increases blood glucose and plasma insulin and decreases plasma levels

2017 Cell reports

249. Relationship between glycated hemoglobin, Intensive Care Unit admission blood sugar and glucose control with ICU mortality in critically ill patients Full Text available with Trip Pro

Relationship between glycated hemoglobin, Intensive Care Unit admission blood sugar and glucose control with ICU mortality in critically ill patients The association between hyperglycemia and mortality is believed to be influenced by the presence of diabetes mellitus (DM). In this study, we evaluated the effect of preexisting hyperglycemia on the association between acute blood glucose management and mortality in critically ill patients. The primary objective of the study was the relationship (...) between HbA1c and mortality in critically ill patients. Secondary objectives of the study were relationship between Intensive Care Unit (ICU) admission blood glucose and glucose control during ICU stay with mortality in critically ill patients.Five hundred patients admitted to two ICUs were enrolled. Blood sugar and hemoglobin A1c (HbA1c) concentrations on ICU admission were measured. Age, sex, history of DM, comorbidities, Acute Physiology and Chronic Health Evaluation II score, sequential organ

2016 Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

250. Relationship between glycated hemoglobin, Intensive Care Unit admission blood sugar and glucose control with Intensive Care Unit mortality in critically ill Full Text available with Trip Pro

Relationship between glycated hemoglobin, Intensive Care Unit admission blood sugar and glucose control with Intensive Care Unit mortality in critically ill 27303146 2016 06 15 2018 11 13 0972-5229 20 4 2016 Apr Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine Indian J Crit Care Med Relationship between glycated hemoglobin, Intensive Care Unit admission blood sugar and glucose control with Intensive Care Unit mortality

2016 Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

251. Effect of Polyherbal Compound for Control of Blood Sugar in Impaired Glucose Tolerance and Diabetes

Effect of Polyherbal Compound for Control of Blood Sugar in Impaired Glucose Tolerance and Diabetes Effect of Polyherbal Compound for Control of Blood Sugar in Impaired Glucose Tolerance and Diabetes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Effect of Polyherbal Compound for Control of Blood Sugar in Impaired Glucose Tolerance and Diabetes The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02866539 Recruitment Status : Completed First Posted : August 15, 2016 Last Update Posted : April 11, 2018

2016 Clinical Trials

252. Blood Glucose Monitors and Test Strips: A Review of the Comparative Clinical Evidence and Cost-Effectiveness ? An Update

Blood Glucose Monitors and Test Strips: A Review of the Comparative Clinical Evidence and Cost-Effectiveness ? An Update Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within (...) for the purposes of research or private study only. It may not be copied, posted on a web site, redistributed by email or stored on an electronic system without the prior written permission of CADTH or applicable copyright owner. Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners’ own terms and conditions. TITLE: Blood Glucose Monitors

2013 Canadian Agency for Drugs and Technologies in Health - Rapid Review

253. Do patients with type 2 diabetes who aren't taking insulin benefit from self-monitoring blood glucose?

Do patients with type 2 diabetes who aren't taking insulin benefit from self-monitoring blood glucose? Do patients with type 2 diabetes who aren't taking insulin benefit from self-monitoring blood glucose? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Do patients with type 2 diabetes who aren't taking insulin benefit (...) from self-monitoring blood glucose? View/ Open Date 2013-01 Format Metadata Abstract Patients with type 2 diabetes who aren't on insulin and perform self-monitoring of blood glucose (SMBG) show small but significant reductions in hemoglobin A1c (HbA1c) at 6 months but not at 12 months (strength of recommendation [SOR]: B, systematic reviews and meta-analyses of disease-oriented evidence). Patients with a baseline HbA1c <8% who self-monitor don't reduce their HbA1c levels, but patients

2013 Clinical Inquiries

254. Blood glucose monitoring in children and adolescents with type 1 diabetes mellitus

Blood glucose monitoring in children and adolescents with type 1 diabetes mellitus Blood glucose monitoring in children and adolescents with type 1 diabetes mellitus Blood glucose monitoring in children and adolescents with type 1 diabetes mellitus Formosa N CRD summary The author concluded that frequent self-monitoring of blood glucose resulted in significant reductions in HbA 1c in children and adolescents with type 1 diabetes. The author’s conclusion reflects the evidence presented but poor (...) reporting of review methods, lack of quality assessment and reporting of study details, and the limited evidence base question the reliability of the conclusions. Authors' objectives To assess the effect of blood glucose monitoring on glycaemic control as measured by HbA 1c in children and adolescents with type 1 diabetes mellitus. Searching MEDLINE (from 1950) and EMBASE (from 1980) were searched up to April 2011. Search terms were reported. Reference lists of retrieved articles were examined. Study

2013 DARE.

255. Association of blood glucose and lipid levels with complete blood count indices to establish a regression model Full Text available with Trip Pro

Association of blood glucose and lipid levels with complete blood count indices to establish a regression model Hyperglycemia and hyperlipidemia, which are usually diagnosed by analysis of blood glucose (GLU) and lipid levels, are two of the most common diseases in modern society. The purpose of the current study was to investigate the potential association between blood GLU and lipid levels with complete blood count (CBC) indices in overweight and healthy individuals and establish a regression (...) model. There were 456 healthy and 421 overweight participants in the study. Data were collected on triglyceride (TG), total cholesterol (CHO), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), blood GLU and CBC. The distribution characteristics and differences between healthy and overweight subjects were analyzed. Subsequently, the associations between TG, CHO, HDL, LDL and GLU with CBC were analyzed using correlation analysis and multiple linear regression

2017 Biomedical reports

256. Astrocytic process plasticity and IKKβ/NF-κB in central control of blood glucose, blood pressure and body weight Full Text available with Trip Pro

Astrocytic process plasticity and IKKβ/NF-κB in central control of blood glucose, blood pressure and body weight Central regulation of metabolic physiology is mediated critically through neuronal functions; however, whether astrocytes are also essential remains unclear. Here we show that the high-order processes of astrocytes in the mediobasal hypothalamus displayed shortening in fasting and elongation in fed status. Chronic overnutrition and astrocytic IKKβ/NF-κB upregulation similarly (...) impaired astrocytic plasticity, leading to sustained shortening of high-order processes. In physiology, astrocytic IKKβ/NF-κB upregulation resulted in early-onset effects, including glucose intolerance and blood pressure rise, and late-onset effects, including body weight and fat gain. Appropriate inhibition in astrocytic IKKβ/NF-κB protected against chronic overnutrition impairing astrocytic plasticity and these physiological functions. Mechanistically, astrocytic regulation of hypothalamic

2017 Cell metabolism

257. Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness ? an update

Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness ? an update Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness — an update Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness — an update CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation (...) of the quality of this assessment has been made for the HTA database. Citation CADTH. Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness — an update. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary with Critical Appraisal. 2013 Authors' conclusions Several blood glucose monitors are available in Canada. Comparative studies of five of these monitors were identified and the devices were shown

2014 Health Technology Assessment (HTA) Database.

258. Effect of self-acupressure on fasting blood sugar (FBS) and insulin level in type 2 diabetes patients: a randomized clinical trial Full Text available with Trip Pro

Effect of self-acupressure on fasting blood sugar (FBS) and insulin level in type 2 diabetes patients: a randomized clinical trial Uncontrolled symptoms of diabetes can lead to irreparable damage to vital organs. Despite the global trend towards the use of complementary alternative therapies, few studies have evaluated the effectiveness of self-acupressure in diabetes patients.The aim of this study was to determine the effect of self-acupressure on FBS and insulin level in type 2 diabetes (...) after treatment in the acupressure group (p=0.001). There were no significant differences between the levels of insulin in study or control groups. Serum FBS level decreased significantly after intervention in the acupressure group compared to the control group (p=0.02).Self-acupressure as a complementary alternative medicine can be a helpful complementary method in reducing FBS and increasing insulin levels in type 2 diabetic patients.This trial was registered at the Iranian Registry of Clinical

2018 Electronic physician Controlled trial quality: uncertain

259. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes

Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2012 DARE.

260. Significance of Blood Sugar and Serum Electrolyte Changes in Cirrhosis Following Glucose, Insulin, Glucagon, or Epinephrine Full Text available with Trip Pro

Significance of Blood Sugar and Serum Electrolyte Changes in Cirrhosis Following Glucose, Insulin, Glucagon, or Epinephrine 13409930 2002 05 01 2018 12 01 0044-0086 29 3 1956 Dec The Yale journal of biology and medicine Yale J Biol Med Significance of blood sugar and serum electrolyte changes in cirrhosis following glucose, insulin, glucagon, or epinephrine. 361-75 DANOWSKI T S TS GILLESPIE H K HK FERGUS E B EB PUNTERERI A J AJ eng Journal Article United States Yale J Biol Med 0417414 0044-0086 (...) 0 Blood Glucose 0 Electrolytes 0 Insulin 9007-92-5 Glucagon IY9XDZ35W2 Glucose YKH834O4BH Epinephrine OM Blood Glucose Electrolytes Epinephrine pharmacology Glucagon pharmacology Glucose pharmacology Humans Insulin pharmacology Liver Cirrhosis blood 5732:7787 EPINEPHRINE/effects GLUCAGON/effects GLUCOSE/effects INSULIN/effects LIVER CIRRHOSIS/blood in 1956 12 1 1956 12 1 0 1 1956 12 1 0 0 ppublish 13409930 PMC2603865 Proc Soc Exp Biol Med. 1953 Apr;82(4):727-30 13055983 J Clin Exp Psychopathol

1956 The Yale journal of biology and medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>